Wulff, K, Gatti, S, Wettstein, JG, Foster, RG.
Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci
2010; 11: 589–99.
Tandon, R, Shipley, JE, Taylor, S, Greden, JF, Eiser, A, DeQuardo, J, et al.
Electroencephalographic sleep abnormalities in schizophrenia. Relationship to positive/negative symptoms and prior neuroleptic treatment. Arch Gen Psychiatry
1992; 49: 185–94.
Lauer, CJ, Schreiber, W, Pollmacher, T, Holsboer, F, Krieg, JC.
Sleep in schizophrenia: a polysomnographic study on drug-naive patients. Neuropsychopharmacology
1997; 16: 51–60.
Nofzinger, EA, van Kammen, DP, Gilbertson, MW, Gurklis, JA, Peters, JL.
Electroencephalographic sleep in clinically stable schizophrenic patients: two-weeks versus six-weeks neuroleptic-free. Biol Psychiatry
1993; 33: 829–35.
Chouinard, S, Poulin, J, Stip, E, Godbout, R.
Sleep in untreated patients with schizophrenia: a meta-analysis. Schizophr Bull
2004; 30: 957–67.
Keshavan, MS, Reynolds, CF 3rd, Miewald, JM, Montrose, DM.
A longitudinal study of EEG sleep in schizophrenia. Psychiatry Res
1996; 59: 203–11.
Keshavan, MS, Miewald, J, Haas, G, Sweeney, J, Ganguli, R, Reynolds, CF.
Slow-wave sleep and symptomatology in schizophrenia and related psychotic disorders. J Psychiatr Res
1995; 29: 303–14.
van Kammen, DP, van Kammen, WB, Peters, J, Goetz, K, Neylan, T.
Decreased slow-wave sleep and enlarged lateral ventricles in schizophrenia. Neuropsychopharmacology
1988; 1: 265–71.
Dijk, DJ, Archer, SN.
PERIOD3, circadian phenotypes, and sleep homeostasis. Sleep Med Rev
2010; 14: 151–60.
Hampp, G, Ripperger, JA, Houben, T, Schmutz, I, Blex, C, Perreau-Lenz, S, et al.
Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood. Curr Biol
2008; 18: 678–83.
Fletcher, PC, Frith, CD.
Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia. Nat Rev Neurosci
2009; 10: 48–58.
Wulff, K, Porcheret, K, Cussans, E, Foster, RG.
Sleep and circadian rhythm disturbances: multiple genes and multiple phenotypes. Curr Opin Genet Dev
2009; 19: 237–46.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
McGuffin, P, Farmer, A, Harvey, I.
A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry
1991; 48: 764–70.
Spitzer, RL, Kroenke, K, Williams, JB.
Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA
1999; 282: 1737–44.
Buysse, DJ, Reynolds, CF III, Monk, TH, Berman, SR, Kupfer, DJ.
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res
1989; 28: 193–213.
Backhaus, J, Junghanns, K, Broocks, A, Riemann, D, Hohagen, F.
Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res
2002; 53: 737–40.
Carpenter, JS, Andrykowski, MA.
Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res
1998; 45: 5–13.
Horne, JA, Ostberg, O.
A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol
1976; 4: 97–110.
McNair, DM, Lorr, M, Droppleman, L.
Manual for the Profile of Mood States. Educational and Industrial Testing Service, 1971.
Frances, A, Pincus, HA, First, MB.
The Global Assessment of Functioning Scale (GAF). American Psychiatric Association, 1994.
Wulff, K, Joyce, EM, Middleton, B, Dijk, DJ, Foster, RG.
The suitability of actigraphy, diary data, and urinary melatonin profiles for quantitative assessment of sleep disturbances in schizophrenia: a case report. Chronobiol Int
2006; 23: 485–95.
Van Someren, EJ, Swaab, DF, Colenda, CC, Cohen, W, McCall, WV, Rosenquist, PB.
Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int
1999; 16: 505–18.
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, 1992.
Aldhous, ME, Arendt, J.
Radioimmunoassay for 6-sulphatoxymelatonin in urine using an iodinated tracer. Ann Clin Biochem
1988; 25: 298–303.
Atkins, M, Burgess, A, Bottomley, C, Riccio, M.
Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications. Psychiatr Bull
1997; 21: 224–6.
Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry
2003; 64: 663–7.
Bai, YM, Ting Chen, T, Chen, JY, Chang, WH, Wu, B, Hung, CH, et al.
Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study. J Clin Psychiatry
2007; 68: 1218–25.
Weitzman, ED, Czeisler, CA, Coleman, RM, Spielman, AJ, Zimmerman, JC, Dement, W, et al.
Delayed sleep phase syndrome. A chronobiological disorder with sleep-onset insomnia. Arch Gen Psychiatry
1981; 38: 737–46.
Hayakawa, T, Uchiyama, M, Kamei, Y, Shibui, K, Tagaya, H, Asada, T, et al.
Clinical analyses of sighted patients with non-24-hour sleep-wake syndrome: a study of 57 consecutively diagnosed cases. Sleep
2005; 28: 945–52.
Weber, AL, Cary, MS, Connor, N, Keyes, P.
Human non-24-hour sleep-wake cycles in an everyday environment. Sleep
1980; 2: 347–54.
Toh, KL, Jones, CR, He, Y, Eide, EJ, Hinz, WA, Virshup, DM, et al.
An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science
2001; 291: 1040–3.
Gronfier, C, Wright, KP Jr, Kronauer, RE, Czeisler, CA.
Entrainment of the human circadian pacemaker to longer-than-24-h days. Proc Natl Acad Sci USA
2007; 104: 9081–6.
Lisman, JE, Coyle, JT, Green, RW, Javitt, DC, Benes, FM, Heckers, S, et al.
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci
2008; 31: 234–42.
Mills, JN, Morgan, R, Minors, DS, Waterhouse, JM.
The free-running circadian rhythms of two schizophrenics. Chronobiologia
1977; 4: 353–60.
Haug, HJ, Wirz-Justice, A, Rossler, W.
Actigraphy to measure day structure as a therapeutic variable in the treatment of schizophrenic patients. Acta Psychiatr Scand Suppl
2000; 102: 91–5.
Wirz-Justice, A, Cajochen, C, Nussbaum, P.
A schizophrenic patient with an arrhythmic circadian rest-activity cycle. Psychiatry Res
1997; 73: 83–90.
Wirz-Justice, A, Haug, HJ, Cajochen, C.
Disturbed circadian rest-activity cycles in schizophrenia patients: an effect of drugs? Schizophr Bull
2001; 27: 497–502.
Martin, J, Jeste, DV, Caliguiri, MP, Patterson, T, Heaton, R, Ancoli-Israel, S.
Actigraphic estimates of circadian rhythms and sleep/wake in older schizophrenia patients. Schizophr Res
2001; 47: 77–86.
Martin, JL, Jeste, DV, Ancoli-Israel, S.
Older schizophrenia patients have more disrupted sleep and circadian rhythms than age-matched comparison subjects. J Psychiatr Res
2005; 39: 251–9.
Krystal, AD, Thakur, M, Roth, T.
Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. Ann Clin Psychiatry
2008; 20: 39–46.
Bromundt, V, Köster, M, Georgiev-Kill, A, Opwis, K, Wirz-Justice, A, Stoppe, G, et al.
Sleep–wake cycles and cognitive functioning in schizophrenia. Br J Psychiatry
2011; 198: 269–76.